These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 27614318)

  • 21. The effect of an artificial tear combining hyaluronic acid and tamarind seeds polysaccharide in patients with moderate dry eye syndrome: a new treatment for dry eye.
    Barabino S; Rolando M; Nardi M; Bonini S; Aragona P; Traverso CE
    Eur J Ophthalmol; 2014; 24(2):173-8. PubMed ID: 24030535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena).
    Vogel R; Crockett RS; Oden N; Laliberte TW; Molina L;
    Am J Ophthalmol; 2010 Apr; 149(4):594-601. PubMed ID: 20346777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 0.025% FK-506, 0.05% Cyclosporin A, and 0.3% Sodium Hyaluronate Eye Drops for the Treatment of Botulinum Toxin B-Induced Mouse Dry Eye.
    Lin BW; Huang WL; Wang L; Chen ZM
    J Ocul Pharmacol Ther; 2018 Nov; 34(9):633-641. PubMed ID: 30227093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease.
    Baeyens V; Bron A; Baudouin C;
    J Fr Ophtalmol; 2012 Jun; 35(6):412-9. PubMed ID: 22483761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye.
    Choi JH; Kim JH; Li Z; Oh HJ; Ahn KY; Yoon KC
    Korean J Ophthalmol; 2015 Apr; 29(2):131-7. PubMed ID: 25829831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye.
    Park Y; Song JS; Choi CY; Yoon KC; Lee HK; Kim HS
    J Ocul Pharmacol Ther; 2017 Mar; 33(2):66-72. PubMed ID: 27929721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 4-week, randomized, double-masked study to evaluate efficacy of deproteinized calf blood extract eye drops versus sodium hyaluronate 0.3% eye drops in dry eye patients with ocular pain.
    Wu Y; Jin X; Mou Y; Yuan K; Min J; Huang X
    Ann Palliat Med; 2021 Apr; 10(4):3617-3625. PubMed ID: 33615815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Tolerability of an Eye Drop Based on 0.6% Povidone-Iodine Nanoemulsion in Dry Eye Patients.
    Oliverio GW; Spinella R; Postorino EI; Inferrera L; Aragona E; Aragona P
    J Ocul Pharmacol Ther; 2021 Mar; 37(2):90-96. PubMed ID: 33370213
    [No Abstract]   [Full Text] [Related]  

  • 29. Discomfort symptoms reduction and ocular surface parameters recovery with Artelac Rebalance treatment in mild-moderate dry eye.
    Versura P; Profazio V; Giannaccare G; Fresina M; Campos EC
    Eur J Ophthalmol; 2013; 23(4):488-95. PubMed ID: 23539457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease: The ESSENCE-2 Randomized Clinical Trial.
    Akpek EK; Wirta DL; Downing JE; Tauber J; Sheppard JD; Ciolino JB; Meides AS; Krösser S
    JAMA Ophthalmol; 2023 May; 141(5):459-466. PubMed ID: 37022717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease.
    Mun Y; Kwon JW; Oh JY
    BMC Ophthalmol; 2018 Sep; 18(1):237. PubMed ID: 30185156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery.
    Mencucci R; Boccalini C; Caputo R; Favuzza E
    J Cataract Refract Surg; 2015 Aug; 41(8):1699-704. PubMed ID: 26432128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
    Kinoshita S; Awamura S; Oshiden K; Nakamichi N; Suzuki H; Yokoi N;
    Ophthalmology; 2012 Dec; 119(12):2471-8. PubMed ID: 23009892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease.
    Tauber J; Wirta DL; Sall K; Majmudar PA; Willen D; Krösser S;
    Cornea; 2021 Sep; 40(9):1132-1140. PubMed ID: 33369937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS; Sung YM; Lee WS; Kim EC
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye: Normal saline vs. artificial tears: A pilot study.
    Vandermeer G; Chamy Y; Pisella PJ
    J Fr Ophtalmol; 2018 Feb; 41(2):e51-e57. PubMed ID: 29366588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy, tolerability and comfort of a 0.3% hypromellose gel ophthalmic lubricant in the treatment of patients with moderate to severe dry eye syndrome.
    Tauber J
    Curr Med Res Opin; 2007 Nov; 23(11):2629-36. PubMed ID: 17868503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trehalose/sodium hyaluronate eye drops in post-cataract ocular surface disorders.
    Cagini C; Torroni G; Mariniello M; Di Lascio G; Martone G; Balestrazzi A
    Int Ophthalmol; 2021 Sep; 41(9):3065-3071. PubMed ID: 33956256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study.
    Prabhasawat P; Tesavibul N; Kasetsuwan N
    Br J Ophthalmol; 2007 Jan; 91(1):47-50. PubMed ID: 16973668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host Disease.
    Sugar A; Hussain M; Chamberlain W; Dana R; Kelly DP; Ta C; Irvine J; Daluvoy M; Perez V; Olson J; Jhanji V; Walts TA; Stulting RD; Waller EK; Jagirdar N;
    Ophthalmol Sci; 2022 Sep; 2(3):100176. PubMed ID: 36245754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.